Nature of Disclosure:
This is a regulatory filing submitted to the BSE Ltd. and the National Stock Exchange of India Limited. The purpose is to disclose the cessation of a senior management personnel as mandated under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Event Details:
- Personnel Affected: Shri G.M. Naidu, who held the position of Manufacturing/ Sr. General Manager, a member of the Senior Management Personnel.
- Reason for Cessation: Resignation due to personal commitments.
- Date of Resignation: The resignation was tendered via email dated June 10, 2026.
- Effective Date of Cessation: The individual was relieved from services with effect from the closure of business hours on August 31, 2026.
Regulatory References:
The disclosure is made pursuant to:
- Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Additional Information:
The submitted annexure confirms there are no applicable relationships between directors to disclose, as this was not an appointment. The resignation email from Shri G.M. Naidu cited a desire to move toward a direction that aligns more closely with his professional aspirations. He expressed gratitude for the opportunities and committed to ensuring a smooth transition.
The information has been made available on the company's website at www.aartipharmalabs.com.
Financial Impact:
Financial impact not quantified in the disclosure.